Literature DB >> 7654579

The anticonvulsant hypersensitivity syndrome.

S E Handfield-Jones1, R E Jenkins, S J Whittaker, C P Besse, D H McGibbon.   

Abstract

Anticonvulsants can cause a characteristic hypersensitivity reaction. This multisystem reaction typically presents as fever, mucocutaneous eruptions, lymphadenopathy and hepatitis. There is cross-reactivity between different anticonvulsants, which complicates subsequent therapy. We report three cases to illustrate both the typical features, and less common complications, of this under-recognized and life-threatening syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7654579     DOI: 10.1111/j.1365-2133.1993.tb03523.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  Anticonvulsant hypersensitivity syndrome in children: incidence, prevention and management.

Authors:  Alberto Verrotti; Daniela Trotta; Carmela Salladini; Francesco Chiarelli
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.

Authors:  S R Knowles; L E Shapiro; N H Shear
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

3.  Cross Hypersensitivity Syndrome between Phenytoin and Carbamazepine.

Authors:  Nerea Moyano Sierra; Benito García; Javier Marco; Susana Plaza; Francisco Hidalgo; Teresa Bermejo
Journal:  Pharm World Sci       Date:  2005-06

4.  Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case report.

Authors:  Mohamed El Ghonemi; Hesham R Omar; Rania Rashad; Jaya Kolla; Devanand Mangar; Enrico Camporesi
Journal:  Cases J       Date:  2009-12-29

5.  Diarrhea, negative t-waves, fever and skin rash, rare manifestation of carbamazepine hypersensitivity: a case report.

Authors:  Felix Aigner; Wolfgang Aigner; Friedrich Hoppichler; Gerhard Luef; Hugo Bonatti
Journal:  Cases J       Date:  2008-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.